Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Current Ratio 2010-2024 | MKKGY

Current and historical current ratio for Merck (MKKGY) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Merck current ratio for the three months ending September 30, 2024 was 1.33.
  
Merck Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-09-30 $15.32B $11.51B 1.33
2024-06-30 $14.05B $10.70B 1.31
2024-03-31 $13.92B $10.79B 1.29
2023-12-31 $13.41B $9.42B 1.43
2023-09-30 $14.76B $9.45B 1.56
2023-06-30 $14.20B $9.65B 1.47
2023-03-31 $13.90B $10.26B 1.36
2022-12-31 $12.86B $10.02B 1.28
2022-09-30 $13.04B $9.48B 1.38
2022-06-30 $13.21B $10.34B 1.28
2022-03-31 $12.44B $11.45B 1.09
2021-12-31 $12.99B $12.34B 1.05
2021-09-30 $12.16B $11.55B 1.05
2021-06-30 $12.27B $11.83B 1.04
2021-03-31 $12.80B $12.84B 1.00
2020-12-31 $10.60B $10.55B 1.01
2020-09-30 $11.99B $11.35B 1.06
2020-06-30 $10.71B $11.10B 0.97
2020-03-31 $11.05B $11.88B 0.93
2019-12-31 $10.08B $13.26B 0.76
2019-09-30 $15.03B $10.74B 1.40
2019-06-30 $13.14B $11.80B 1.11
2019-03-31 $11.94B $12.71B 0.94
2018-12-31 $10.91B $10.06B 1.08
2018-09-30 $9.71B $10.43B 0.93
2018-06-30 $9.75B $9.86B 0.99
2018-03-31 $9.60B $10.49B 0.92
2017-12-31 $8.43B $9.76B 0.86
2017-09-30 $8.85B $9.61B 0.92
2017-06-30 $8.67B $9.82B 0.88
2017-03-31 $8.56B $9.94B 0.86
2016-12-31 $8.49B $10.06B 0.84
2016-09-30 $8.13B $9.50B 0.86
2016-06-30 $8.20B $9.51B 0.86
2016-03-31 $8.15B $9.97B 0.82
2015-12-31 $8.16B $10.41B 0.78
2015-09-30 $18.49B $5.86B 3.15
2015-06-30 $15.34B $5.88B 2.61
2015-03-31 $16.57B $6.00B 2.76
2014-12-31 $13.93B $8.78B 1.59
2014-09-30 $9.70B $7.73B 1.26
2014-06-30 $8.51B $7.07B 1.21
2014-03-31 $10.61B $7.01B 1.51
2013-12-31 $9.81B $5.18B 1.89
2013-09-30 $9.77B $5.40B 1.81
2013-06-30 $9.77B $5.87B 1.67
2013-03-31 $9.40B $6.10B 1.54
2012-12-31 $8.52B $5.87B 1.45
2012-09-30 $8.93B $6.25B 1.43
2012-06-30 $8.43B $5.06B 1.67
2012-03-31 $0.00B 0.00
2011-12-31 $8.91B $6.08B 1.47
2011-09-30 $0.00B 0.00
2011-06-30 $8.75B $5.12B 1.71
2011-03-31 $0.00B 0.00
2010-12-31 $0.00B 0.00
2010-09-30 $7.59B $4.97B 1.53
2010-06-30 $0.00B 0.00
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
2009-06-30 $0.00B 0.00
2009-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.496B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.178B 28.93
Chugai Pharmaceutical (CHGCY) Japan $69.572B 27.10
Takeda Pharmaceutical (TAK) Japan $41.014B 8.54
Sandoz Group AG (SDZNY) Switzerland $20.363B 0.00
Summit Therapeutics (SMMT) United States $17.345B 0.00
Astellas Pharma (ALPMY) Japan $17.101B 15.75
United Therapeutics (UTHR) United States $16.576B 16.31
Neurocrine Biosciences (NBIX) United States $14.859B 39.35
Shionogi (SGIOY) Japan $12.088B 12.11
Orion OYJ (ORINY) Finland $7.253B 20.39
Madrigal Pharmaceuticals (MDGL) United States $7.082B 0.00
Stevanato Group S.p.A (STVN) Italy $6.517B 42.20
Corcept Therapeutics (CORT) United States $6.185B 46.85
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.456B 0.00
Ionis Pharmaceuticals (IONS) United States $5.132B 0.00
Grifols, S.A (GRFS) Spain $5.088B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.953B 7.87
Crinetics Pharmaceuticals (CRNX) United States $3.584B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.927B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.728B 12.36
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.640B 15.78
Centessa Pharmaceuticals (CNTA) United Kingdom $2.199B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.159B 0.00
Soleno Therapeutics (SLNO) United States $2.088B 0.00
Hypermarcas (HYPMY) Brazil $1.983B 0.00
Indivior (INDV) United States $1.666B 6.79
BioCryst Pharmaceuticals (BCRX) United States $1.578B 0.00
Evotec AG (EVO) Germany $1.464B 0.00
Xencor (XNCR) United States $1.447B 0.00
Dyne Therapeutics (DYN) United States $1.436B 0.00
Guardian Pharmacy Services (GRDN) United States $1.333B 0.00
ARS Pharmaceuticals (SPRY) United States $1.317B 0.00
Ocular Therapeutix (OCUL) United States $1.256B 0.00
Harrow (HROW) United States $1.230B 0.00
Ardelyx (ARDX) United States $1.196B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.107B 0.00
Enliven Therapeutics (ELVN) United States $1.077B 0.00
Collegium Pharmaceutical (COLL) United States $1.050B 5.73
Relay Therapeutics (RLAY) United States $0.824B 0.00
Bioventus (BVS) United States $0.819B 25.87
Avadel Pharmaceuticals (AVDL) Ireland $0.771B 0.00
Cronos Group (CRON) Canada $0.734B 0.00
Verve Therapeutics (VERV) United States $0.660B 0.00
USANA Health Sciences (USNA) United States $0.648B 12.02
Ironwood Pharmaceuticals (IRWD) United States $0.595B 0.00
Elite Pharmaceuticals (ELTP) United States $0.529B 0.00
Akebia Therapeutics (AKBA) United States $0.521B 0.00
Altimmune (ALT) United States $0.494B 0.00
Xeris Biopharma Holdings (XERS) United States $0.490B 0.00
ProKidney (PROK) United States $0.487B 0.00
Savara (SVRA) United States $0.475B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.460B 0.00
Siga Technologies (SIGA) United States $0.456B 5.32
Tourmaline Bio (TRML) United States $0.452B 0.00
OmniAb (OABI) United States $0.452B 0.00
Organogenesis (ORGO) United States $0.440B 0.00
Oruka Therapeutics (ORKA) United States $0.437B 0.00
Zevra Therapeutics (ZVRA) United States $0.435B 0.00
Esperion Therapeutics (ESPR) United States $0.433B 0.00
KalVista Pharmaceuticals (KALV) United States $0.423B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.384B 155.79
Korro Bio (KRRO) United States $0.357B 0.00
Aldeyra Therapeutics (ALDX) United States $0.300B 0.00
Aquestive Therapeutics (AQST) United States $0.286B 0.00
CytoDyn (CYDY) United States $0.270B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 16.02
Heron Therapeutics (HRTX) United States $0.248B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.239B 0.00
Avita Medical (RCEL) United States $0.222B 0.00
Larimar Therapeutics (LRMR) United States $0.221B 0.00
Profound Medical (PROF) Canada $0.217B 0.00
4D Molecular Therapeutics (FDMT) United States $0.213B 0.00
MediWound (MDWD) Israel $0.199B 0.00
Inhibikase Therapeutics (IKT) United States $0.194B 0.00
VAXART, INC (VXRT) United States $0.186B 0.00
Aclaris Therapeutics (ACRS) United States $0.186B 0.00
Acrivon Therapeutics (ACRV) United States $0.174B 0.00
Nektar Therapeutics (NKTR) United States $0.169B 0.00
Lyell Immunopharma (LYEL) United States $0.168B 0.00
Silence Therapeutics (SLN) United Kingdom $0.163B 0.00
Lexeo Therapeutics (LXEO) United States $0.162B 0.00
Nanobiotix S.A (NBTX) France $0.151B 0.00
Champions Oncology (CSBR) United States $0.148B 0.00
Telomir Pharmaceuticals (TELO) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.138B 0.00
Cassava Sciences (SAVA) United States $0.125B 0.00
Jupiter Neurosciences (JUNS) United States $0.119B 0.00
Inotiv (NOTV) United States $0.115B 0.00
Metagenomi (MGX) United States $0.113B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.109B 0.00
ElectroCore (ECOR) United States $0.106B 0.00
Achieve Life Sciences (ACHV) Canada $0.106B 0.00
Protara Therapeutics (TARA) United States $0.097B 0.00
Pyxis Oncology (PYXS) United States $0.093B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Karyopharm Therapeutics (KPTI) United States $0.084B 0.00
Nutriband (NTRB) United States $0.082B 0.00
AleAnna (ANNA) United States $0.081B 0.00
Regulus Therapeutics (RGLS) United States $0.081B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.25
Journey Medical (DERM) United States $0.077B 0.00
Galectin Therapeutics (GALT) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Century Therapeutics (IPSC) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Context Therapeutics (CNTX) United States $0.070B 0.00
Avalo Therapeutics (AVTX) United States $0.069B 0.00
PMV Pharmaceuticals (PMVP) United States $0.068B 0.00
OptiNose (OPTN) United States $0.067B 0.00
Mural Oncology (MURA) Ireland $0.067B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.065B 0.00
Prelude Therapeutics (PRLD) United States $0.064B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
FibroGen (FGEN) United States $0.051B 0.00
AlloVir (ALVR) United States $0.046B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
SCYNEXIS (SCYX) United States $0.040B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
CASI Pharmaceuticals (CASI) China $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
Scienture Holdings (SCNX) United States $0.038B 0.00
Surrozen (SRZN) United States $0.038B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.037B 0.00
BioVie (BIVI) United States $0.036B 0.00
Incannex Healthcare (IXHL) Australia $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Citius Pharmaceuticals (CTXR) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Vivos Therapeutics (VVOS) United States $0.024B 0.00
Lipocine (LPCN) United States $0.023B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.023B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Traws Pharma (TRAW) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.012B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
BioLineRx (BLRX) Israel $0.009B 0.00
Dominari Holdings (DOMH) United States $0.009B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.006B 0.00
SciSparc (SPRC) Israel $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.09
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00